A Randomized Control Trial of Cognitive Behavioral Therapy on Adherence and Depression (CBT-AD) Among HIV/AIDS Patients on Follow up at Mattu Karl and Bedele Hospital, 2019
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Depression
- Sponsor
- Mattu University
- Enrollment
- 128
- Locations
- 1
- Primary Endpoint
- The mean score of Depression will change after intervention
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
Depression is highly comorbid with HIV/ AIDS and is associated with worse poor adherence to antiretroviral therapy (ART), and potentially to long-term immune functioning. Cognitive behavioral therapy may solve these problem.
Detailed Description
Depression is highly comorbid with HIV/ AIDS and is associated with worse poor adherence to antiretroviral therapy (ART), and potentially to long-term immune functioning. Poor adherence decreases the benefits of ART as well as chances of prolonged survival. An intervention that integrates CBT for depression with a cognitive behavioral approach to adherence counseling (cognitive behavioral therapy intervention for adherence and depression (CBT-AD)) has been found to be effective in improving adherence and reducing depression in PLWH.
Investigators
Zakir Abdu
Assistant Professor of Psychiatry
Mattu University
Eligibility Criteria
Inclusion Criteria
- •PLWHA who were 18 years old and above were included in the study
Exclusion Criteria
- •PLWHA who were previously took CBT and participants with acute physical or mental disturbances were excluded.
Outcomes
Primary Outcomes
The mean score of Depression will change after intervention
Time Frame: Through study completion, an average of 1 yea
Depression is measured by Patient Health Questionnaire (PHQ-9) Depression Scale. The minimum value is 0 and the maximum value is 27. The higher score mean worse outcome